Insights

Biotech IPO Kallyope Inc. recently went public, signaling potential growth and investment opportunities for interested stakeholders.

New GPCR Target Kallyope Inc. has identified a new G protein-coupled receptor (GPCR) target for gastrointestinal diseases, offering a novel solution that could attract partnerships and collaborations.

Grant Funding Receiving a substantial grant from the Bill & Melinda Gates Foundation reflects the confidence in Kallyope Inc.'s research and development capabilities, potentially leading to expanded projects and collaborations in the health sector.

High-Caliber Hires Bringing in experienced professionals like Franz Humer, Michael Crutchlow, Shirly Pinto, and Jiajun Liu demonstrates Kallyope Inc.'s commitment to strengthening its expertise and capabilities, offering networking opportunities for potential business partnerships.

Market Positioning In a competitive landscape with similar biotech companies like 23andMe and Arvinas, Kallyope Inc.'s focus on oral agents for metabolic, neurological, and gastrointestinal diseases sets it apart, presenting unique sales propositions to potential clients and investors.

Kallyope Tech Stack

Kallyope uses 8 technology products and services including Fastly, MySQL, Microsoft Excel, and more. Explore Kallyope's tech stack below.

  • Fastly
    Content Delivery Network
  • MySQL
    Database
  • Microsoft Excel
    Editors
  • Amazon Web Services
    Platform As A Service
  • Node.js
    Programming Languages
  • C++
    Programming Languages
  • New Relic
    Real User Monitoring
  • Paylocity
    Recruitment Marketing

Media & News

Kallyope's Email Address Formats

Kallyope uses at least 1 format(s):
Kallyope Email FormatsExamplePercentage
First@kallyope.comJohn@kallyope.com
33%
First.Last@kallyope.comJohn.Doe@kallyope.com
17%
First@kallyope.comJohn@kallyope.com
33%
First.Last@kallyope.comJohn.Doe@kallyope.com
17%

Frequently Asked Questions

Where is Kallyope's headquarters located?

Minus sign iconPlus sign icon
Kallyope's main headquarters is located at 430 E. 29th Street New York, New York 10016 US. The company has employees across 5 continents, including North AmericaEuropeAfrica.

What is Kallyope's phone number?

Minus sign iconPlus sign icon
You can contact Kallyope's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Kallyope's official website and social media links?

Minus sign iconPlus sign icon
Kallyope's official website is kallyope.com and has social profiles on LinkedIn.

How much revenue does Kallyope generate?

Minus sign iconPlus sign icon
As of October 2024, Kallyope's annual revenue reached $35M.

What is Kallyope's SIC code NAICS code?

Minus sign iconPlus sign icon
Kallyope's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Kallyope have currently?

Minus sign iconPlus sign icon
As of October 2024, Kallyope has approximately 74 employees across 5 continents, including North AmericaEuropeAfrica. Key team members include Chief Scientific Officer: S. P.Chief Financial Officer: P. E. F.Chief Medical Officer: B. L.. Explore Kallyope's employee directory with LeadIQ.

What industry does Kallyope belong to?

Minus sign iconPlus sign icon
Kallyope operates in the Biotechnology Research industry.

What technology does Kallyope use?

Minus sign iconPlus sign icon
Kallyope's tech stack includes FastlyMySQLMicrosoft ExcelAmazon Web ServicesNode.jsC++New RelicPaylocity.

What is Kallyope's email format?

Minus sign iconPlus sign icon
Kallyope's email format typically follows the pattern of . Find more Kallyope email formats with LeadIQ.

How much funding has Kallyope raised to date?

Minus sign iconPlus sign icon
As of October 2024, Kallyope has raised $8.2M in funding. The last funding round occurred on May 10, 2023 for $8.2M.

When was Kallyope founded?

Minus sign iconPlus sign icon
Kallyope was founded in 2015.
Kallyope

Kallyope

Biotechnology ResearchNew York, United States51-200 Employees

At Kallyope, we focus on big health challenges that matter to patients and families. We aim to discover and develop effective, easy to use, and well-tolerated oral agents addressing metabolic, neurological, and gastrointestinal diseases. 

Inside every human body is a complex, unexplored network of metabolic, neurological, and gastrointestinal interconnections. Our scientists are unlocking the mysteries of this network to develop oral therapies for obesity and diabetes; neurological disorders, including migraine; and gastrointestinal disease, including celiac disease.

Based in New York City, we are home to some of the world’s most intrepid scientific minds from the world’s top institutions, working alongside a seasoned team with a proven track record of success in drug discovery and development.

Together, we are leveraging multiple sophisticated technologies and internally-developed capabilities to bring fundamentally new solutions to some of the most pressing unmet needs in human health.

Section iconCompany Overview

Headquarters
430 E. 29th Street New York, New York 10016 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $8.2M

    Kallyope has raised a total of $8.2M of funding over 6 rounds. Their latest funding round was raised on May 10, 2023 in the amount of $8.2M.

  • $10M$50M

    Kallyope's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $8.2M

    Kallyope has raised a total of $8.2M of funding over 6 rounds. Their latest funding round was raised on May 10, 2023 in the amount of $8.2M.

  • $10M$50M

    Kallyope's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.